ARCHIVES

FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

FASEB Urges Better Funding, Management Of Biomedical Research

February 23, 1996

Avon, NABCO Accepting Grant Applications For Community-Based Breast Cancer Programs

June 9, 1995

White House Backs Down FY 86 Cuts, Says Now They Will Be Limited To Trimming Indirect Costs

January 10, 1986

Letter to the Editor: IOM Study Welcome For “Omic” Research

October 29, 2010

NCCS Networker Volume 10 Issue 1, Spring 1996

April 13, 1996

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010